202 related articles for article (PubMed ID: 26934299)
1. Tumor Autonomous Effects of Vitamin D Deficiency Promote Breast Cancer Metastasis.
Williams JD; Aggarwal A; Swami S; Krishnan AV; Ji L; Albertelli MA; Feldman BJ
Endocrinology; 2016 Apr; 157(4):1341-7. PubMed ID: 26934299
[TBL] [Abstract][Full Text] [Related]
2. Identification of tumor-autonomous and indirect effects of vitamin D action that inhibit breast cancer growth and tumor progression.
Aggarwal A; Feldman D; Feldman BJ
J Steroid Biochem Mol Biol; 2018 Mar; 177():155-158. PubMed ID: 28710021
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D mitigates the adverse effects of obesity on breast cancer in mice.
Swami S; Krishnan AV; Williams J; Aggarwal A; Albertelli MA; Horst RL; Feldman BJ; Feldman D
Endocr Relat Cancer; 2016 Apr; 23(4):251-64. PubMed ID: 26817629
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D receptor modulates the neoplastic phenotype through antagonistic growth regulatory signals.
Xu H; McCann M; Zhang Z; Posner GH; Bingham V; El-Tanani M; Campbell FC
Mol Carcinog; 2009 Aug; 48(8):758-72. PubMed ID: 19184984
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D receptor is involved in the regulation of human breast cancer cell growth via a ligand-independent function in cytoplasm.
Trivedi T; Zheng Y; Fournier PGJ; Murthy S; John S; Schillo S; Dunstan CR; Mohammad KS; Zhou H; Seibel MJ; Guise TA
Oncotarget; 2017 Apr; 8(16):26687-26701. PubMed ID: 28460457
[TBL] [Abstract][Full Text] [Related]
6. Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.
Verone-Boyle AR; Shoemaker S; Attwood K; Morrison CD; Makowski AJ; Battaglia S; Hershberger PA
Oncotarget; 2016 Jan; 7(1):995-1013. PubMed ID: 26654942
[TBL] [Abstract][Full Text] [Related]
7. Long-term vitamin D deficiency in older adult C57BL/6 mice does not affect bone structure, remodeling and mineralization.
van der Meijden K; Buskermolen J; van Essen HW; Schuurman T; Steegenga WT; Brouwer-Brolsma EM; Langenbach GEJ; van Ruijven LJ; den Heijer M; Lips P; Bravenboer N
J Steroid Biochem Mol Biol; 2016 Nov; 164():344-352. PubMed ID: 26361014
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D deficiency is associated with greater tumor size and poorer outcome in Merkel cell carcinoma patients.
Samimi M; Touzé A; Laude H; Le Bidre E; Arnold F; Carpentier A; Gardair C; Carlotti A; Maubec E; Dupin N; Aubin F; Avril MF; Rozenberg F; Avenel-Audran M; Guyetant S; Lorette G; Machet L; Coursaget P
J Eur Acad Dermatol Venereol; 2014 Mar; 28(3):298-308. PubMed ID: 23368852
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D
Bunch BL; Ma Y; Attwood K; Amable L; Luo W; Morrison C; Guru KA; Woloszynska-Read A; Hershberger PA; Trump DL; Johnson CS
Cancer Med; 2019 May; 8(5):2449-2461. PubMed ID: 30972950
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and breast cancer: inhibition of estrogen synthesis and signaling.
Krishnan AV; Swami S; Feldman D
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):343-8. PubMed ID: 20156557
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency promotes human breast cancer growth in a murine model of bone metastasis.
Ooi LL; Zhou H; Kalak R; Zheng Y; Conigrave AD; Seibel MJ; Dunstan CR
Cancer Res; 2010 Mar; 70(5):1835-44. PubMed ID: 20160035
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and VDR in cancer cachexia and muscle regeneration.
Camperi A; Pin F; Costamagna D; Penna F; Menduina ML; Aversa Z; Zimmers T; Verzaro R; Fittipaldi R; Caretti G; Baccino FM; Muscaritoli M; Costelli P
Oncotarget; 2017 Mar; 8(13):21778-21793. PubMed ID: 28423519
[TBL] [Abstract][Full Text] [Related]
13. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
14. Tumor Expression of Vitamin D Receptor and Breast Cancer Histopathological Characteristics and Prognosis.
Al-Azhri J; Zhang Y; Bshara W; Zirpoli G; McCann SE; Khoury T; Morrison CD; Edge SB; Ambrosone CB; Yao S
Clin Cancer Res; 2017 Jan; 23(1):97-103. PubMed ID: 27407090
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of β-catenin activity.
Johnson AL; Zinser GM; Waltz SE
Oncotarget; 2015 Jun; 6(18):16304-20. PubMed ID: 26008979
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D-gene interactions in multiple sclerosis.
Berlanga-Taylor AJ; Disanto G; Ebers GC; Ramagopalan SV
J Neurol Sci; 2011 Dec; 311(1-2):32-6. PubMed ID: 22000399
[TBL] [Abstract][Full Text] [Related]
17. Predisposition to vitamin D deficiency osteomalacia and rickets in females is linked to their 25(OH)D and calcium intake rather than vitamin D receptor gene polymorphism.
Ray D; Goswami R; Gupta N; Tomar N; Singh N; Sreenivas V
Clin Endocrinol (Oxf); 2009 Sep; 71(3):334-40. PubMed ID: 19094076
[TBL] [Abstract][Full Text] [Related]
18. Activation of vitamin D receptor signaling downregulates the expression of nuclear FOXM1 protein and suppresses pancreatic cancer cell stemness.
Li Z; Jia Z; Gao Y; Xie D; Wei D; Cui J; Mishra L; Huang S; Zhang Y; Xie K
Clin Cancer Res; 2015 Feb; 21(4):844-53. PubMed ID: 25501129
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of growth arrest and CYP24 induction by VDR ligands in mammary tumor cells.
Valrance ME; Brunet AH; Acosta A; Welsh J
J Cell Biochem; 2007 Aug; 101(6):1505-19. PubMed ID: 17286279
[TBL] [Abstract][Full Text] [Related]
20. Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.
Gupta A; Montepiedra G; Gupte A; Zeldow B; Jubulis J; Detrick B; Violari A; Madhi S; Bobat R; Cotton M; Mitchell C; Spector S;
PLoS One; 2016; 11(2):e0148649. PubMed ID: 26872154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
